Compare BRCC & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRCC | IXHL |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.3M | 45.0M |
| IPO Year | 2022 | 2024 |
| Metric | BRCC | IXHL |
|---|---|---|
| Price | $0.82 | $3.52 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.25 | N/A |
| AVG Volume (30 Days) | ★ 477.0K | 468.7K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $398,263,000.00 | $12,000.00 |
| Revenue This Year | $9.68 | N/A |
| Revenue Next Year | $9.59 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.73 | N/A |
| 52 Week Low | $0.60 | $0.11 |
| 52 Week High | $2.40 | $6.39 |
| Indicator | BRCC | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 52.57 | 59.82 |
| Support Level | $0.71 | $0.34 |
| Resistance Level | $1.09 | $3.68 |
| Average True Range (ATR) | 0.05 | 0.35 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 65.29 | 87.39 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.